Read the full press release on Dr. Sadiq's invitation to present at the Second International Adult Stem Cell Conference: Regenerative Medicine - A Fundamental Shift in Science and Culture.

Dear Patients,

The FDA has officially approved Tecfidera as of March 27, 2013. We know many patients will be interested in switching to this new oral medication. We welcome this as a potentially important new medication however a change in treatment is an important medical decision and must be discussed with your physician. Please keep in mind although the FDA has approved the medication, it is not available on the market as of yet and once made available will almost certainly...

A poster on the relationship between oxidative stress and chemokines in multiple sclerosis (MS) was presented and well received last week at the American Academy of Neurology meeting in San Diego. To summarize our investigation, chemokines are known to modulate generation of reactive oxygen species (ROS) at the site of inflammation. This association between ROS and inflammation, was viewed as a one-way process, i.e. immune cells activated by chemokines produced ROS. However, excessive ROS...

Researchers from your Tisch MS Research Center of New York will be presenting 4 posters at the American Academy of Neurology 2013 meeting in San Diego this week!  IMSMP Neurologists are also in attendance and will bring us updates throughout the week!